FDA approves Mylan's generic version of Prilosec
Mylan receives FDA final approval for generic version of heartburn drug Prilosec
- On 9:01 am EST, Friday January 23, 2009
PITTSBURGH (AP) -- Drug developer Mylan Inc. said Friday federal regulators have given final approval to an application to make a generic version of the heartburn drug Prilosec.
The U.S. Food and Drug Administration approved an abbreviated new drug application for omeprazole delayed-release capsules, 40 mg, Mylan said in a statement.
The capsules are approved for the treatment of peptic ulcers and gastroesophageal reflux disease. Mylan said it would ship the drug immediately.
Prilosec is made by AstraZeneca PLC.
Mylan shares closed at $11.14 in trading Thursday.
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
Earn From 1.90% to 2.20% Apply Online
With GE Capital Corporation. Not An Offer Of Securities For Sale.
-
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today. -
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month.
Tech Ticker Recent Posts
Add Alert Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.